Skip to content

Intelligence

The deal

Type
Funding
Amount
€40M
Status
Announced
Round
Seed
Valuation
Not recorded
Region
Italy
Date
29 September 2026

As of this development: a later development may record new terms.

Lifecycle

  1. Announced29 September 2026 · This development
  2. ClosedNot recorded

The parties

Aptadir Therapeutics Issuer

1 development · 1 deal in Minutes

4BIO Capital Lead investor

1 development · 1 deal in Minutes

EXTEND Investor

1 development · 1 deal in Minutes